| Date Filed | Type | Description |
| 10/12/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/12/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/12/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/12/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/04/2023 |
4
| SIEGALL CLAY B (President and CEO) has filed a Form 4 on Immunome Inc.|
Txns:
| Bought 169,204 shares
@ $5.91, valued at
$1000k
|
|
| 10/04/2023 |
3
| SIEGALL CLAY B (President and CEO) has filed a Form 3 on Immunome Inc. |
| 10/04/2023 |
4
| Turner Bruce (Chief Strategy Officer) has filed a Form 4 on Immunome Inc.|
Txns:
| Bought 42,300 shares
@ $5.91, valued at
$250k
|
|
| 10/04/2023 |
3
| Turner Bruce (Chief Strategy Officer) has filed a Form 3 on Immunome Inc. |
| 10/04/2023 |
4
| PRENDERGAST FRANKLYN G (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 60,840 shares
@ $0
Granted 137,725 options to buy
@ $1.35, valued at
$185.9k
|
|
| 10/03/2023 |
4
| RAPP MICHAEL (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 253,806 shares
@ $5.91, valued at
$1.5M
|
|
| 06/12/2023 |
4
| RAPP MICHAEL (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 6,500 options to buy
@ $4.84, valued at
$31.5k
|
|
| 06/12/2023 |
4
| Stoneman Sandra G. (General Counsel and CLO) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 56,000 options to buy
@ $4.84, valued at
$271k
|
|
| 06/12/2023 |
4
| Roche Corleen M. (CFO) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 58,000 options to buy
@ $4.84, valued at
$280.7k
|
|
| 06/12/2023 |
4
| ROBINSON MATTHEW K (Chief Technology Officer) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 58,000 options to buy
@ $4.84, valued at
$280.7k
|
|
| 06/12/2023 |
4
| Sarma Purnanand D (President and CEO) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 166,500 options to buy
@ $4.84, valued at
$805.9k
|
|
| 06/12/2023 |
4
| Lefenfeld Michael (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 6,500 options to buy
@ $4.84, valued at
$31.5k
|
|
| 06/12/2023 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 6,500 options to buy
@ $4.84, valued at
$31.5k
|
|
| 06/12/2023 |
4
| BARON RICHARD A (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 6,500 options to buy
@ $4.84, valued at
$31.5k
|
|
| 06/12/2023 |
4
| PRENDERGAST FRANKLYN G (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 6,500 options to buy
@ $4.84, valued at
$31.5k
|
|
| 06/12/2023 |
4
| WAGENHEIM PHILIP (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 6,500 options to buy
@ $4.84, valued at
$31.5k
|
|
| 06/12/2023 |
4
| Giesing Dennis H (Chief Development Officer) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.84, valued at
$242k
|
|
| 01/17/2023 |
4
| WAGENHEIM PHILIP (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 8,750 shares
@ $4, valued at
$35k
|
|
| 01/17/2023 |
4
| LAMATTINA JOHN L (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 15,125 shares
@ $4, valued at
$60.5k
|
|
| 01/17/2023 |
4
| Lefenfeld Michael (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 13,875 shares
@ $4, valued at
$55.5k
|
|
| 01/17/2023 |
4
| RAPP MICHAEL (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 17,500 shares
@ $4, valued at
$70k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| ROBINSON MATTHEW K (Chief Technology Officer) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 35,000 options to buy
@ $3.42, valued at
$119.7k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Lefenfeld Michael (Director) has filed a Form 4 on Immunome Inc.|
Txns:
| Granted 6,500 options to buy
@ $2.62, valued at
$17k
|
|
|